title: [Betaserc treatment of acute disorders of cerebral circulation with vestibulo-ataxic and cochleo-vestibular syndromes].
authors.forename: M Ia
authors.initials: MIa
authors.lastname: Berdichevskiĭ
authors.forename: S A
authors.initials: SA
authors.lastname: Karmirian
authors.forename: I I
authors.initials: II
authors.lastname: Geĭko
authors.forename: V E
authors.initials: VE
authors.lastname: Miroshnichenko
authors.forename: T N
authors.initials: TN
authors.lastname: Parkhaeva
authors.forename: V G
authors.initials: VG
authors.lastname: Popova
authors.forename: L V
authors.initials: LV
authors.lastname: Timchenko
authors.forename: T V
authors.initials: TV
authors.lastname: Filina
authors.forename: L A
authors.initials: LA
authors.lastname: Aristova
mesh_terms: D000208:Acute Disease; D001621:Betahistine / Q000627:therapeutic use*; D002524:Cerebellar Ataxia / Q000150:complications*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D017442:Histamine Agonists / Q000627:therapeutic use*; D006801:Humans; D002546:Ischemic Attack, Transient / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D020521:Stroke / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D013577:Syndrome; D016896:Treatment Outcome; D000159:Vestibulocochlear Nerve / Q000503:physiopathology
chemical_list: D017442:Histamine Agonists; D001621:Betahistine